Ahren Innovation Capital

Really excited about our $40M Series A led by Khosla Ventures and Ahren Innovation Capital, and the support of leaders like Vinod Khosla Alexander A. Morgan, MD PhD, , Robert Gould, Alice Newcombe-Ellis, Joanna Green and others! These fundings support Rubedo transitioning to clinical stage our first program in the pipeline focused on chronic inflammatory skin conditions emerging from our discovery platform ALEMBIC with a first-in-class new molecule. Those skin conditions are large medical needs, typically aggravated in the elderly, and, regardless of the chronological age, they can manifest in any individual with a biologically aged skin. Skin is an entry point to then move beyond to other tissues and organs and other chronic diseases. Hevolution Foundation R42 Group Refactor Capital Knollwood Investment Advisory LongeVC Shanda Group Modi Ventures IAG

Today marks an exciting day as we finally launch Mentee Robotics to the public and unveil the MenteeBot, a humanoid robot that integrates AI across all its operational layers.   The prototype unveiled today, though not the final version, demonstrates for the first time a complete end-to-end cycle from a verbal command to complex task completion, including navigation, locomotion, scene understanding, object detection and localization and natural language understanding.   Locomotion, for example, is based on a novel Sim2Real machine-learning approach, wherein reinforcement learning occurs on a simulated version of the robot – thus utilizing unlimited data for training, followed by adaptation to the real world. The mapping of the environment is performed on the fly using NeRF-based algorithms. These cognitive maps store semantic information, allowing the robot to query them to find items and places. Transformer-based Large Language Models (LLMs) are used to interpret commands and “think through” the required steps to complete the task with an emphasis on the ability to integrate locomotion and dexterity (i.e., dynamically balancing the robot when carrying weights).   We are on the cusp of a convergence of computer vision, natural language understanding, strong and detailed simulators, and methodologies for transferring simulations to the real world. At Mentee Robotics, we see this convergence as the starting point for designing the future general-purpose robot that can move everywhere with the brains to perform household tasks and learn completely new tasks through imitation.   Mentee Robotics has operated in stealth mode for the past two years. Now, finally comes the time to showcase all that we have been working on. This is truly just the beginning

Ahren is proud to be partnering with Sunfire and an incredible group of co-investors in the company's €500M fundraise! This new round of financing will enable Sunfire to significantly increase the deployment of its electrolysis technologies, which are critical enablers for the decarbonization of hard-to-abate industries.

🚨 Bitfount joins NVIDIA Inception program! We are delighted to have been selected to join the NVIDIA Inception program. We're looking forward to engaging with the wider NVIDIA community as well as strengthening our existing integrations with NVIDIA's software, hardware and cloud solutions. Get in touch to learn more about the problems federated data science and AI can solve for your business. #NVIDIAInception #federatedAI

Congratulations Blaise Thomson, Naaman Tammuz, Matthew Seigel and the whole Bitfount team for a very well deserved "Best Innovation in Pharma" award at CogX!

Congratulations Amnon Shashua, Yoav Shoham, Ori Goshen, and the superb team at AI21 Labs on achieving unicorn status! This announcement marks yet another major milestone on your journey to deliver accurate, trustworthy, and reliable foundation models to consumers and enterprises alike via your Studio platform and Wordtune suite. We are proud to be partnered with you. Watch this space everyone!

Congratulations to the whole Heirloom team and its partners Climeworks and Battelle on being selected by the U.S. Department of Energy (DOE) for its $3.5BN Regional Direct Air Capture Hubs program. This is a significant and very well deserved achievement on the road towards removing a billion tons of CO2 per year by 2035.

We are delighted to announce that our portfolio company, Adrestia Therapeutics , which we co-founded alongside Ahren Science Partner Professor Sir Stephen (Steve) Jackson, has been acquired by Insmed Incorporated.    Since its co-founding by, and seed funding from, Ahren and Series A financing from Ahren and GSK, Adrestia has deepened its unique synthetic rescue capabilities and platform. In applying synthetic rescue principles to the entire human genome, Adrestia has achieved identification of targets with potential applicability in various serious and rare diseases.    Alice Newcombe-Ellis, General Partner of Ahren added, “Ahren was established to help enable great scientific and tech founders to achieve their visions, while changing the world for the better. We are delighted to have co-founded a company with Sir Steve that might not have otherwise existed and supported him, Rob, and team to this terrific outcome for the company and for patients.”   Full article can be found here https://lnkd.in/epzFfRiA